For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit
May 24, 2019

Biomedical Business Plan Challenge Nurtures Weill Cornell Medicine Entrepreneurs

Iris was one of seven companies formed by Weill Cornell Medicine investigators that participated in the Business Plan Challenge. The groups competed in Griffis Faculty Club in front of a panel of seven expert judges comprised of investors who specialize in early-stage companies, for investment capital for their NewCos  to help commercialize their technologies.

March 27, 2018

Du Cheng, 29

Now an M.D.-Ph.D. student, Du Cheng was initially rejected from college and later from all but one medical school. But he has since distinguished himself by balancing the rigors of studying medicine with running his own startup, iDu Optics, which has generated more than $500,000 in revenue.

March 22, 2018

The Entrepreneurs

Fostering a Culture of Innovation, Weill Cornell Medicine is Making it Faster and Easier for Researchers to Move their Discoveries From Bench to Bedside

May 26, 2017

Running the Numbers

Computational Biology Student Neel Madhukar Designs a Powerful Tool for Optimizing Drug Development.

May 23, 2017

Baby Steps

Infertility affects about 12 percent of American couples. Celmatix, a New York City-based personalized medicine company focused on reproductive health, is trying to change that.

May 5, 2017

Pioneering Program Teaches Students How to Commercialize Medical Technologies

As an undergraduate student, Du Cheng invented a laboratory camera adapter that would allow scientists to capture images with an iPhone and then view them through a microscope.

August 4, 2014

Moneyball Could Offer Winning Strategy for Drug Development

Researchers at Weill Cornell Medicine have developed a promising new AI tool that better predicts which drug candidates are likely to be too toxic—and it’s based on the Oakland A’s winning strategy, immortalized in the blockbuster book and movie Moneyball.